Abstract
The beneficial effects of infliximab, the tumour necrosis factor antibody, in Crohn's disease may be mediated by apoptosis of activated mucosal T cells.
Cite
CITATION STYLE
APA
Sturm, A., & Fiocchi, C. (2002). Life and death in the gut: More killing, less Crohn’s. Gut. BMJ Publishing Group. https://doi.org/10.1136/gut.50.2.148
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free